Review



mouse glucocorticoid-induced tnfr-related protein ligand-fusion protein (gitrl-fp) migg2a  (AstraZeneca ltd)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    AstraZeneca ltd mouse glucocorticoid-induced tnfr-related protein ligand-fusion protein (gitrl-fp) migg2a
    Mouse Glucocorticoid Induced Tnfr Related Protein Ligand Fusion Protein (Gitrl Fp) Migg2a, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gitrl-fp/mouse+glucocorticoid+induced+tnfr+related+protein+ligand+fusion+protein++gitrl+fp++migg2a/pmc08215240-41-12-17
    Average 90 stars, based on 1 article reviews
    mouse glucocorticoid-induced tnfr-related protein ligand-fusion protein (gitrl-fp) migg2a - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    Produced:

    Article Title: Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional <i>STK11</i> Mutations in Patients with Non–Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown
    Article Snippet: Drug treatments included: anti-mouse PD-L1 mIgG1 D265A clone 80 (anti-mouse PD-L1 lacking effector function, produced by AstraZeneca, 10 mg/kg twice weekly); anti-mouse CTLA4 mIgG1 clone 9D9 (anti-mouse CTLA4 lacking effector function, produced by AstraZeneca, 10 mg/kg twice weekly); anti-mouse OX40 clone OX86 mIgG2a (anti-mouse OX40 mAb with effector function, produced by AstraZeneca, 0.1 mg/kg, one dose at randomization); anti-mouse CD137 mIgG1 (produced by AstraZeneca, 0.1 mg/kg, one dose at randomization); anti-mouse ICOS mIgG2a (anti-mouse ICOS with effector function, produced by AstraZeneca, 0.1 mg/kg, one dose at randomization); anti-mouse IL6 rat IgG1 mAb clone MP5–20F3 (Bio-X-Cell; 1 mg/kg twice weekly); AZD2014 mTORC1/2 inhibitor (AstraZeneca, daily oral gavage, 15 mg/kg, 2 days on 5 days off treatment); AZD5069 CXCR2 inhibitor (AstraZeneca, twice-daily oral gavage, 100 mg/kg); AZD7507 CSF1R inhibitor (AstraZeneca, twice-daily oral gavage, 50 mg/kg); anti-mouse STAT3 ASO (Ionis Pharmaceuticals, Inc. and AstraZeneca, once-daily subcutaneous injection, 50 mg/kg, 5 days on 2 days off treatment).

    Article Title: Novel non-terminal tumor sampling procedure using fine needle aspiration supports immuno-oncology biomarker discovery in preclinical mouse models
    Article Snippet: Mice were randomized by body weight and dosed with mouse glucocorticoid-induced TNFR-related protein ligand-fusion protein (GITRL-FP) mIgG2a (AstraZeneca) intraperitoneally at 0.2 mg/kg or 1 mg/kg 6 days after tumor cell implantation.

    Allele-specific Oligonucleotide:

    Article Title: Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional <i>STK11</i> Mutations in Patients with Non–Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown
    Article Snippet: Drug treatments included: anti-mouse PD-L1 mIgG1 D265A clone 80 (anti-mouse PD-L1 lacking effector function, produced by AstraZeneca, 10 mg/kg twice weekly); anti-mouse CTLA4 mIgG1 clone 9D9 (anti-mouse CTLA4 lacking effector function, produced by AstraZeneca, 10 mg/kg twice weekly); anti-mouse OX40 clone OX86 mIgG2a (anti-mouse OX40 mAb with effector function, produced by AstraZeneca, 0.1 mg/kg, one dose at randomization); anti-mouse CD137 mIgG1 (produced by AstraZeneca, 0.1 mg/kg, one dose at randomization); anti-mouse ICOS mIgG2a (anti-mouse ICOS with effector function, produced by AstraZeneca, 0.1 mg/kg, one dose at randomization); anti-mouse IL6 rat IgG1 mAb clone MP5–20F3 (Bio-X-Cell; 1 mg/kg twice weekly); AZD2014 mTORC1/2 inhibitor (AstraZeneca, daily oral gavage, 15 mg/kg, 2 days on 5 days off treatment); AZD5069 CXCR2 inhibitor (AstraZeneca, twice-daily oral gavage, 100 mg/kg); AZD7507 CSF1R inhibitor (AstraZeneca, twice-daily oral gavage, 50 mg/kg); anti-mouse STAT3 ASO (Ionis Pharmaceuticals, Inc. and AstraZeneca, once-daily subcutaneous injection, 50 mg/kg, 5 days on 2 days off treatment).

    Article Title: Novel non-terminal tumor sampling procedure using fine needle aspiration supports immuno-oncology biomarker discovery in preclinical mouse models
    Article Snippet: Mice were randomized by body weight and dosed with mouse glucocorticoid-induced TNFR-related protein ligand-fusion protein (GITRL-FP) mIgG2a (AstraZeneca) intraperitoneally at 0.2 mg/kg or 1 mg/kg 6 days after tumor cell implantation.

    Injection:

    Article Title: Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional <i>STK11</i> Mutations in Patients with Non–Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown
    Article Snippet: Drug treatments included: anti-mouse PD-L1 mIgG1 D265A clone 80 (anti-mouse PD-L1 lacking effector function, produced by AstraZeneca, 10 mg/kg twice weekly); anti-mouse CTLA4 mIgG1 clone 9D9 (anti-mouse CTLA4 lacking effector function, produced by AstraZeneca, 10 mg/kg twice weekly); anti-mouse OX40 clone OX86 mIgG2a (anti-mouse OX40 mAb with effector function, produced by AstraZeneca, 0.1 mg/kg, one dose at randomization); anti-mouse CD137 mIgG1 (produced by AstraZeneca, 0.1 mg/kg, one dose at randomization); anti-mouse ICOS mIgG2a (anti-mouse ICOS with effector function, produced by AstraZeneca, 0.1 mg/kg, one dose at randomization); anti-mouse IL6 rat IgG1 mAb clone MP5–20F3 (Bio-X-Cell; 1 mg/kg twice weekly); AZD2014 mTORC1/2 inhibitor (AstraZeneca, daily oral gavage, 15 mg/kg, 2 days on 5 days off treatment); AZD5069 CXCR2 inhibitor (AstraZeneca, twice-daily oral gavage, 100 mg/kg); AZD7507 CSF1R inhibitor (AstraZeneca, twice-daily oral gavage, 50 mg/kg); anti-mouse STAT3 ASO (Ionis Pharmaceuticals, Inc. and AstraZeneca, once-daily subcutaneous injection, 50 mg/kg, 5 days on 2 days off treatment).

    Article Title: Novel non-terminal tumor sampling procedure using fine needle aspiration supports immuno-oncology biomarker discovery in preclinical mouse models
    Article Snippet: Mice were randomized by body weight and dosed with mouse glucocorticoid-induced TNFR-related protein ligand-fusion protein (GITRL-FP) mIgG2a (AstraZeneca) intraperitoneally at 0.2 mg/kg or 1 mg/kg 6 days after tumor cell implantation.



    Similar Products

    medi1873 hexameric gitrl fusion protein (gitrl fp)  (AstraZeneca ltd)
    90
    AstraZeneca ltd medi1873 hexameric gitrl fusion protein (gitrl fp)
    Structure of GITR agonists being evaluated in ongoing or completed clinical trials
    Medi1873 Hexameric Gitrl Fusion Protein (Gitrl Fp), supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gitrl-fp/medi1873/pmc10278658-11-16-2
    Average 90 stars, based on 1 article reviews
    medi1873 hexameric gitrl fusion protein (gitrl fp) - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    mouse glucocorticoid-induced tnfr-related protein ligand-fusion protein (gitrl-fp) migg2a  (AstraZeneca ltd)
    90
    AstraZeneca ltd mouse glucocorticoid-induced tnfr-related protein ligand-fusion protein (gitrl-fp) migg2a
    Structure of GITR agonists being evaluated in ongoing or completed clinical trials
    Mouse Glucocorticoid Induced Tnfr Related Protein Ligand Fusion Protein (Gitrl Fp) Migg2a, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gitrl-fp/mouse+glucocorticoid+induced+tnfr+related+protein+ligand+fusion+protein++gitrl+fp++migg2a/pmc08215240-41-12-17
    Average 90 stars, based on 1 article reviews
    mouse glucocorticoid-induced tnfr-related protein ligand-fusion protein (gitrl-fp) migg2a - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    gitrl-fp antibody  (AstraZeneca ltd)
    90
    AstraZeneca ltd gitrl-fp antibody
    Structure of GITR agonists being evaluated in ongoing or completed clinical trials
    Gitrl Fp Antibody, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gitrl-fp/amp+224/pmc09398146-55-12-15
    Average 90 stars, based on 1 article reviews
    gitrl-fp antibody - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    gitrl-fp (mouse igg2a  (AstraZeneca ltd)
    90
    AstraZeneca ltd gitrl-fp (mouse igg2a
    Structure of GITR agonists being evaluated in ongoing or completed clinical trials
    Gitrl Fp (Mouse Igg2a, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gitrl-fp/amp+224/10__1158_slash_1535___7163__mct___20___0902-181-9-12
    Average 90 stars, based on 1 article reviews
    gitrl-fp (mouse igg2a - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    gitrl-fp  (MedImmune llc)
    90
    MedImmune llc gitrl-fp
    Structure of GITR agonists being evaluated in ongoing or completed clinical trials
    Gitrl Fp, supplied by MedImmune llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gitrl-fp/gitrl+fp/pm28649380-19-1-14
    Average 90 stars, based on 1 article reviews
    gitrl-fp - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    mouse gitr ligand fusion protein (gitrl fp)  (MedImmune llc)
    90
    MedImmune llc mouse gitr ligand fusion protein (gitrl fp)
    Structure of GITR agonists being evaluated in ongoing or completed clinical trials
    Mouse Gitr Ligand Fusion Protein (Gitrl Fp), supplied by MedImmune llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gitrl-fp/mouse+gitr+ligand+fusion+protein++gitrl+fp+/pm28283653-39-8-18
    Average 90 stars, based on 1 article reviews
    mouse gitr ligand fusion protein (gitrl fp) - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    gitrl fp protein  (Thermo Fisher)
    90
    Thermo Fisher gitrl fp protein
    Structure of GITR agonists being evaluated in ongoing or completed clinical trials
    Gitrl Fp Protein, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gitrl-fp/gitrl+fp+protein/10__1080_slash_2162402x__2017__1280645-34-0-30
    Average 90 stars, based on 1 article reviews
    gitrl fp protein - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Structure of GITR agonists being evaluated in ongoing or completed clinical trials

    Journal: Oncotarget

    Article Title: Targeting GITR in cancer immunotherapy – there is no perfect knowledge

    doi: 10.18632/oncotarget.28461

    Figure Lengend Snippet: Structure of GITR agonists being evaluated in ongoing or completed clinical trials

    Article Snippet: MEDI1873 , AstraZeneca , Hexameric GITRL fusion protein (GITRL FP) comprising 2 GITRL ECD trimers and IgG1 Fc linked by isoleucine zipper trimerization domain , Fully human IgG1 , Yes , Hexavalent.

    Techniques: Binding Assay